Literature DB >> 20803184

A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors.

Vesna Jacob1, Wolfgang Bayer, Sabrina T Astner, R Busch, Peter Kneschaurek.   

Abstract

PURPOSE: A comparative analysis of the three most advanced intensity-modulated radiotherapy (IMRT) techniques currently commercially available was performed. Treatment plans made in rotational techniques (helical tomotherapy [HT] and RapidArc) were compared with sliding-window IMRT (dIMRT) on a conventional linear accelerator using different leaf thicknesses (2.5 mm, 5 mm, and 10 mm). The influence of the different planning techniques on the coverage of planning volume and sparing of organs at risk (OARs) was investigated. PATIENTS AND METHODS: Nine patients with localized prostate and nine patients with head and neck cancer were chosen for this study. Treatment planning was performed in Eclipse (Varian) and in Tomotherapy planning software. Treatment plans were compared according to target volume coverage and sparing OARs, as well as by conformity and homogeneity index.
RESULTS: For both investigated tumor sites, the dosimetric effects of leaf widths between 2.5 mm, 5 mm and 10 mm were shown to be small in regard to target coverage. Tomotherapy plans had better target coverage (higher minimum dose). For prostate cancer, better sparing of bladder and rectum was achieved with RapidArc and dIMRT plans. For head and neck cancer, best sparing of parotid glands was achieved in HT plans. There was no significant difference (p > 0.05) in sparing of OARs between the dIMRT plans with different leaf widths neither for prostate cancer nor for head and neck cancer.
CONCLUSION: For prostate and head and neck cases, all investigated IMRT techniques provide highly conformal treatment plans in terms of both target coverage and critical structure sparing.

Entities:  

Mesh:

Year:  2010        PMID: 20803184     DOI: 10.1007/s00066-010-2124-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  32 in total

1.  Dosimetric effect of collimating jaws for small multileaf collimated fields.

Authors:  James C L Chow; Melanie Seguin; Andrew Alexander
Journal:  Med Phys       Date:  2005-03       Impact factor: 4.071

2.  Inverse planning--a comparative intersystem and interpatient constraint study.

Authors:  Dietmar Georg; Bernhard Kroupa; Petra Georg; Peter Winkler; Joachim Bogner; Karin Dieckmann; Richard Pötter
Journal:  Strahlenther Onkol       Date:  2006-08       Impact factor: 3.621

3.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

4.  Overestimation of low-dose radiation in intensity-modulated radiotherapy with sliding-window technique.

Authors:  Hilke Vorwerk; Daniela Wagner; Björn Seitz; Hans Christiansen; Hendrik A Wolff; Clemens F Hess
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

5.  Comparison of advanced irradiation techniques with photons for benign intracranial tumours.

Authors:  L Cozzi; A Clivio; G Bauman; S Cora; G Nicolini; R Pellegrini; E Vanetti; S Yartsev; A Fogliata
Journal:  Radiother Oncol       Date:  2006-08-04       Impact factor: 6.280

6.  A comparison of prostate IMRT and helical tomotherapy class solutions.

Authors:  George Rodrigues; Slav Yartsev; Jeff Chen; Eugene Wong; David D'Souza; Michael Lock; Glenn Bauman; Grigor Grigorov; Tomas Kron
Journal:  Radiother Oncol       Date:  2006-08-01       Impact factor: 6.280

7.  Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study.

Authors:  Claudio Fiorino; Italo Dell'Oca; Alessio Pierelli; Sara Broggi; Giovanni Mauro Cattaneo; Anna Chiara; Elena De Martin; Nadia Di Muzio; Ferruccio Fazio; Riccardo Calandrino
Journal:  Strahlenther Onkol       Date:  2007-09       Impact factor: 3.621

8.  Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques.

Authors:  Antonella Fogliata; Alessandro Clivio; Giorgia Nicolini; Eugenio Vanetti; Luca Cozzi
Journal:  Radiother Oncol       Date:  2008-08-28       Impact factor: 6.280

9.  Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution.

Authors:  Yi-Jen Chen; An Liu; Chunhui Han; Peter T Tsai; Timothy E Schultheiss; Richard D Pezner; Nilesh Vora; Dean Lim; Stephen Shibata; Kemp H Kernstine; Jeffrey Y C Wong
Journal:  Med Dosim       Date:  2007       Impact factor: 1.482

10.  Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.

Authors:  Pengpeng Zhang; Laura Happersett; Margie Hunt; Andrew Jackson; Michael Zelefsky; Gig Mageras
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-18       Impact factor: 7.038

View more
  34 in total

1.  Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Dirk Rades; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Steven E Schild; Christoph Thorns
Journal:  Strahlenther Onkol       Date:  2011-09-19       Impact factor: 3.621

2.  Reduction of dosimetric impact of intrafractional prostate motion during helical tomotherapy.

Authors:  V Prokic; H Geinitz; P Kneschaurek
Journal:  Strahlenther Onkol       Date:  2012-02-16       Impact factor: 3.621

3.  Chest wall radiotherapy with volumetric modulated arcs and the potential role of flattening filter free photon beams.

Authors:  S Subramaniam; S Thirumalaiswamy; C Srinivas; G A Gandhi; M Kathirvel; K K Kumar; S Mallik; M Babaiah; Y Pawar; A Clivio; A Fogliata; P Mancosu; G Nicolini; E Vanetti; L Cozzi
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

4.  High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

Authors:  O P Erpolat; P U Gocun; M Akmansu; E Karakus; G Akyol
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

5.  RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma.

Authors:  G Z Gong; Y Yin; L G Xing; Y J Guo; T Liu; J Chen; J Lu; C Ma; T Sun; T Bai; G Zhang; R Wang
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

6.  The potential of helical tomotherapy in the treatment of head and neck cancer.

Authors:  Dirk Van Gestel; Dirk Verellen; Lien Van De Voorde; Bie de Ost; Geert De Kerf; Olivier Vanderveken; Carl Van Laer; Danielle Van den Weyngaert; Jan B Vermorken; Vincent Gregoire
Journal:  Oncologist       Date:  2013-05-30

7.  Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer.

Authors:  Bettina Hentschel; Wolfgang Oehler; Dirk Strauss; Andreas Ulrich; Ansgar Malich
Journal:  Strahlenther Onkol       Date:  2011-02-24       Impact factor: 3.621

8.  Breast cancer and funnel chest. Comparing helical tomotherapy and three-dimensional conformal radiotherapy with regard to the shape of pectus excavatum.

Authors:  M Uhl; F Sterzing; G Habl; K Schubert; H Holger; J Debus; K Herfarth
Journal:  Strahlenther Onkol       Date:  2012-01-06       Impact factor: 3.621

Review 9.  [Radiation-related caries: etiology and possible preventive strategies. What should the radiotherapist know?].

Authors:  R Schweyen; J Hey; W Fränzel; D Vordermark; G Hildebrandt; T Kuhnt
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

10.  Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.

Authors:  Tanja Langsenlehner; Wilfried Renner; Armin Gerger; Günter Hofmann; Eva-Maria Thurner; Karin S Kapp; Uwe Langsenlehner
Journal:  Strahlenther Onkol       Date:  2011-11-17       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.